Zoledronic acid blocks the interaction between breast cancer cells and regulatory T-cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Zoledronic acid blocks the interaction between breast cancer cells and regulatory T-cells
Authors
Keywords
Regulatory T-cells, Zoledronic acid, Breast cancer, Immunomodulation
Journal
BMC CANCER
Volume 19, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-02-26
DOI
10.1186/s12885-019-5379-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune modulation of CD4+CD25+ regulatory T cells by zoledronic acid
- (2016) Hsien Liu et al. BMC IMMUNOLOGY
- Targeting regulatory T cells in tumors
- (2016) Chang Liu et al. FEBS Journal
- Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma
- (2016) X Wang et al. ONCOGENE
- Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts
- (2016) Giuseppina Comito et al. Oncotarget
- Zoledronic acid in the management of metastatic bone disease
- (2016) Thomas Polascik Therapeutics and Clinical Risk Management
- The differential anti-tumour effects of zoledronic acid in breast cancer – evidence for a role of the activin signaling pathway
- (2015) Caroline Wilson et al. BMC CANCER
- PD-1 Upregulated on Regulatory T Cells during Chronic Virus Infection Enhances the Suppression of CD8+T Cell Immune Response via the Interaction with PD-L1 Expressed on CD8+T Cells
- (2015) Hyo Jin Park et al. JOURNAL OF IMMUNOLOGY
- Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma
- (2015) Iris Chiara Salaroglio et al. Oncotarget
- Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12
- (2014) M. Gnant et al. ANNALS OF ONCOLOGY
- Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial
- (2014) Robert Coleman et al. LANCET ONCOLOGY
- Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
- (2012) R. Coleman et al. ANNALS OF ONCOLOGY
- Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid
- (2012) Toni Ibrahim et al. Cancer Cell International
- Tumor-Derived Chemokine CCL5 Enhances TGF- -Mediated Killing of CD8+ T Cells in Colon Cancer by T-Regulatory Cells
- (2012) L.-Y. Chang et al. CANCER RESEARCH
- Suppression, subversion and escape: the role of regulatory T cells in cancer progression
- (2012) K. Oleinika et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- High Phosphoantigen Levels in Bisphosphonate-Treated Human Breast Tumors Promote V 9V 2 T-Cell Chemotaxis and Cytotoxicity In Vivo
- (2011) I. Benzaid et al. CANCER RESEARCH
- Early Detection of Tumor Cells by Innate Immune Cells Leads to Treg Recruitment through CCL22 Production by Tumor Cells
- (2011) J. Faget et al. CANCER RESEARCH
- Immune Modulation by Zoledronic Acid in Human Myeloma: An Advantageous Cross-Talk between V 9V 2 T Cells, CD8+ T Cells, Regulatory T Cells, and Dendritic Cells
- (2011) B. Castella et al. JOURNAL OF IMMUNOLOGY
- Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice
- (2010) Takashi Kikuiri et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bisphosphonates pathway
- (2010) Li Gong et al. Pharmacogenetics and Genomics
- Clinical Use of Anti-CD25 Antibody Daclizumab to Enhance Immune Responses to Tumor Antigen Vaccination by Targeting Regulatory T cells
- (2009) Andrew J. Rech et al. Annals of the New York Academy of Sciences
- CCL2 Blockade Augments Cancer Immunotherapy
- (2009) Z. G. Fridlender et al. CANCER RESEARCH
- Systemic inflammatory response and downmodulation of peripheral CD25+Foxp3+ T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer
- (2009) Anna Maria Fietta et al. HUMAN IMMUNOLOGY
- Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway
- (2009) Marta Coscia et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- NK-Dependent Increases in CCL22 Secretion Selectively Recruits Regulatory T Cells to the Tumor Microenvironment
- (2009) A. W. Mailloux et al. JOURNAL OF IMMUNOLOGY
- Tumor Regulatory T Cells Potently Abrogate Antitumor Immunity
- (2009) Zuqiang Liu et al. JOURNAL OF IMMUNOLOGY
- RANK-RANKL Signaling Pathway Is Critically Involved in the Function of CD4 + CD25 + Regulatory T Cells in Chronic Colitis
- (2009) Teruji Totsuka et al. JOURNAL OF IMMUNOLOGY
- CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer
- (2008) Yoshiki Mizukami et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer
- (2008) Paul Salama et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-derived TGF-β Mediates Conversion of CD4+Foxp3+ Regulatory T Cells in a Murine Model of Pancreas Cancer
- (2008) Tricia A. Moo-Young et al. JOURNAL OF IMMUNOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started